Patent details

92182 Product Name: Dapagliflozine et ses sels pharmaceutiquement acceptables

Basic Information

Publication number:
92182
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP037366432
Legal Status:
Active
Application number:
92182
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
07/11/2022
SPC Extension Agent Name:
MARKS & CLERK LLP
SPC Extension Status:
Granted
SPC Extension Grant Date:
04/10/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/12/795/001-10
Marketing Authorization Type:
Marketing Authorization Date:
14/11/2012
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
17/04/2013
First Marketing Authorization date:
14/11/2012
Grant date:
17/06/2013
Activation date:
15/05/2023
Publication date:
17/06/2013
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
14/11/2027
SPC Extension Expiration:
14/05/2028
Rejection date:
Withdrawal date:

Owner

From:
08/04/2014
 
 

Name:
ASTRAZENECA AB
Address:
VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

History of Owners

From:
17/04/2013
To:
07/04/2014

Name:
BRISTOL-MYERS SQUIBB COMPANY
Address:
ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NEW JERSEY 08543-4000, United States (US)

Agent

Name:
MARKS & CLERK LLP
From:
17/04/2013
Address:
BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
To:

Inventor

1

Name:
ELLSWORTH Bruce
Address:
United States (US)

2

Name:
WU Gang
Address:
United States (US)

3

Name:
MENG Wei
Address:
United States (US)

4

Name:
SHER Philip, M.
Address:
United States (US)

5

Name:
WASHBURN William, N.
Address:
United States (US)

Publication

Bulletin

1

Bulletin Heading:
SPC4
Bulletin edition number:
2019/02
Publication date:
22/02/2019
Description:
Section F : Correction of granted supplementary protection certificates – I9 publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2022/13
Publication date:
01/12/2022
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/13
Publication date:
05/11/2024
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

4

Bulletin Heading:
SPC3
Bulletin edition number:
2025/04
Publication date:
04/03/2025
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
24
Annual Fee Amount:
440 Euro
Expected Payer:
Last Annual Fee Payment Date:
23/04/2025
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
430 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)